Evidence map›Paper›PMID 41970310›Full record

ArticleClinical case reports2026

When Meningioma Travels: Rare Extracranial Metastasis-Case and Review.

Tala Najdi, Sami Abi Farraj, Pierre El Sett, Clarisse Kattan, Antoine El Sett, Antoine Chartouni, Patrick Ghorayeb, Ghadi Dagher, Rhea Khazen, Fares Azoury and 2 more

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tala NajdiDepartment of Hematology-Oncology Hotel-Dieu de France University Hospital Beirut Lebanon.ORCID https://orcid.org/0009-0004-3090-127X
Sami Abi FarrajFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Pierre El SettFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Clarisse KattanDepartment of Hematology-Oncology Hotel-Dieu de France University Hospital Beirut Lebanon.
Antoine El SettFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Antoine ChartouniFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Patrick GhorayebFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Ghadi DagherFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Rhea KhazenFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Fares AzouryFaculty of Medicine Saint Joseph University of Beirut Beirut Lebanon.
Joseph KattanDepartment of Hematology-Oncology Hotel-Dieu de France University Hospital Beirut Lebanon.
Hampig KourieDepartment of Hematology-Oncology Hotel-Dieu de France University Hospital Beirut Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are the most common primary intracranial tumors; extracranial metastases occur in < 1% of cases, most often to the lungs or bone. Hepatic spread is exceptionally rare and is more common in atypical or recurrent disease. A 73-year-old man with a recurrent left frontal atypical meningioma (Grade II, 2016 WHO CNS classification) developed a 4 × 3 cm hepatic lesion 12 years after initial diagnosis. Liver biopsy revealed spindle-cell proliferation positive for EMA and negative for S100 protein, consistent with metastatic meningioma. Subsequent intracranial resection showed focal anaplastic transformation (Grade 3, 2021 WHO CNS classification) with Ki-67 up to 20%. Treatment with Sandostatin and Everolimus stabilized the hepatic lesion, although intracranial recurrences persisted and the patient died during a surgical brain resection of a recurrence from a massive intraoperative hemorrhage. This exceptionally rare hepatic metastasis from an atypical meningioma emphasizes the possible need for long-term systemic surveillance. Repeated recurrences, high mitotic activity, and histologic transformation may predict metastatic potential. Our review of the last decade identified only a few similar extracranial cases, supporting targeted imaging and individualized therapy in high-risk meningiomas.

Indexed as

atypical meningiomaextracranial spreadhepatic metastasishistologic transformation

Identifiers

PMID41970310
PMCPMC13069006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.